Please provide your email address to receive an email when new articles are posted on . The live attenuated varicella-zoster vaccine is safe and provides “reasonable short-term” effectiveness in ...
The investigators noted that parental refusal of vaccination is an increasing problem, owing to a combination of concern over vaccine safety combined with a belief that children are at low risk for ...
Two articles focus on recent changes in the use and effects of the varicella-zoster vaccine in older adults and the varicella vaccine in children. These two reports address the effects of ...
PRIMARY varicella pneumonia is a clinical entity that has been described as a rare and severe disease in adults. 1–3 Since the first report in 1942 by Waring and his associates, 1 approximately 50 ...
The Centers for Disease Control and Prevention has temporarily paused testing for rabies, mpox, and other viruses, raising ...
Please provide your email address to receive an email when new articles are posted on . Over the past several months, two new agents have become available to aid clinicians in preventing infections ...
Consistent with previous reports, mean antibody levels increased over time by a geometric mean of 66% per year in subjects with titers of less than 10 units (Table 1, line D). However, they decreased ...
The committee voted for separate MMR and varicella vaccines for the first dose in toddlers. The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) ...
Congenital varicella syndrome is a rare complication of infection with maternal varicella before 20 weeks of pregnancy. Prospective studies in Europe and North America have shown that the incidence of ...
This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
Dublin, July 31, 2025 (GLOBE NEWSWIRE) -- The "Chicken Pox Market - A Global and Regional Analysis: Focus on Type of Vaccine, Drug Class, and Region - Analysis and Forecast, 2025-2035" report has been ...